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Introduction {#sec1}
============

Recognition of influenza virus infection by the innate immune system plays a key role not only in limiting viral replication at early stages of infection but also in initiating the virus-specific adaptive immune responses ([@bib17]). Toll-like receptor 7 (TLR7) recognizes influenza virus genomic RNA in endosomes ([@bib9]; [@bib21]). In cytosol, retinoic acid inducible gene I (RIG-I) detects the 5′ triphosphate end of influenza genomic RNA ([@bib11]; [@bib33]; [@bib35]; [@bib43]). These two recognition pathways lead to the induction of type I interferons to restrict influenza virus replication. In contrast to TLRs and RIG-I-like helicases that recognize viral RNA, the NLRP3 senses cellular damage or distress induced by viral infection ([@bib2]). Upon activation, NLRP3 is recruited to the mitochondria ([@bib15]; [@bib40]) or dispersed *trans-*Golgi network ([@bib4]) to form the multi-molecular protein complex termed the NLRP3 inflammasome. The NLRP3 inflammasome activates caspase-1, which cleaves the precursor forms of proinflammatory cytokines, interleukin 1 beta (IL-1β) and IL-18, and stimulates their secretion ([@bib10]; [@bib18]; [@bib37]). These inflammasome-dependent cytokines play a key role in the induction of adaptive immune responses and the initiation of tissue healing responses to influenza virus infection ([@bib1]; [@bib12], [@bib14]; [@bib28]; [@bib32]; [@bib42]).

Thus far, several possible mechanisms could explain how the NLRP3 detects influenza virus infection. First, influenza virus M2 protein, a proton-selective ion channel, stimulates ion flux from the *trans-*Golgi network and activates the NLRP3 inflammasome ([@bib13]). Second, phagocytosed PB1-F2 aggregates induce mitochondrial reactive oxygen species (ROS) production and stimulate the NLRP3 inflammasome-mediated IL-1β secretion from macrophages ([@bib26]; [@bib34]). Third, Z-DNA binding protein 1 (ZBP1) senses the ribonucleoprotein (RNP) complex to facilitate influenza virus-induced NLRP3 inflammasome activation ([@bib19]). However, the precise mechanisms of NLRP3 inflammasome activation by influenza virus M2 and PB1-F2 proteins remain unclear.

Recently, we demonstrated that the ion channel activity of influenza virus M2 protein is essential for mitochondrial DNA (mtDNA) release into the cytosol ([@bib29]). In addition, recent studies highlight the importance of oxidized mtDNA in NLRP3 inflammasome activation ([@bib38]; [@bib46]). Consistent with these observations, we and others have shown that mtDNA-depleted ρ0 J774A.1 or bone marrow-derived macrophages (BMMs) abrogated caspase-1 activation and IL-1β secretion ([@bib15]; [@bib30]; [@bib47]). These observations prompted us to examine whether influenza virus-induced oxidized mtDNA may trigger the NLRP3 inflammasome activation. Here we examined the mechanisms by which influenza virus stimulates oxidized mtDNA release into the cytosol and role of oxidized mtDNA in influenza virus-induced NLRP3 inflammasome activation.

Results {#sec2}
=======

Influenza A Virus Triggers Oxidized DNA Release from Macrophages {#sec2.1}
----------------------------------------------------------------

We previously demonstrated that influenza virus stimulates cytosolic mtDNA release in mouse lung fibroblasts, human A549, and human embryonic kidney cell line 293FT (HEK293FT) cells ([@bib29]). To determine whether influenza virus stimulates mtDNA release in macrophages, we infected J774A.1 macrophages with influenza virus A/PR8 strain. Although influenza virus replication was abortive in J774A.1 macrophages ([Figure S1](#mmc1){ref-type="supplementary-material"}A), we detected productive translation of the viral proteins ([Figure 1](#fig1){ref-type="fig"}A). To detect mtDNA in the cytosol, we first extracted pure cytosolic fraction from mock- or virus-infected J774A.1 macrophages ([Figure 1](#fig1){ref-type="fig"}A). Analysis of the pure cytosolic extracts demonstrated that cytosolic release of mtDNA as well as nuclear DNA became apparent starting around 4 h post infection (p.i.) and peaking around 9 h p.i. ([Figures 1](#fig1){ref-type="fig"}B, 1C, [S1](#mmc1){ref-type="supplementary-material"}B, and S1C). In addition, we detected significant amounts of mtDNA and nuclear DNA in the supernatants of influenza virus-infected J774A.1 macrophages as early as 8 h p.i. ([Figures 1](#fig1){ref-type="fig"}D, 1E, [S1](#mmc1){ref-type="supplementary-material"}D, and S1E). Consistent with this observation, we observed double-stranded DNA (dsDNA) in extracellular web-like structures from influenza virus-infected J774A.1 and BMMs ([Figures 1](#fig1){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}F). Furthermore, we detected oxidized DNA in the pure cytosolic fraction of influenza virus-infected J774A.1 macrophages ([Figure 1](#fig1){ref-type="fig"}G). In addition, a recent A/Narita/1/2009 (H1N1) strain stimulated cytosolic mtDNA release and IL-1β secretion from J774A.1 macrophages ([Figures S1](#mmc1){ref-type="supplementary-material"}G--S1I). Together, these data suggest that influenza virus stimulates oxidized DNA release in macrophages.Figure 1Influenza Virus Triggers Oxidized DNA Release from Macrophages(A) J774A.1 macrophages were subjected to digitonin fractionation as described in [Methods](#sec4){ref-type="sec"} and pellets (P) or cytosolic extracts (C) were analyzed by western blotting using the indicated antibodies.(B--E) J774A.1 macrophages were infected with PR8 virus. Pure cytosolic extracts and supernatants were collected at indicated time points. Relative levels of mtDNA (B and D) or nuclear DNA (C and E) in the cytosol and supernatants were assessed by quantitative PCR.(F) J774A.1 macrophages were infected with PR8 virus. At 24 h post infection, cells were stained with anti-dsDNA (AC-30-10) and anti-Tom20 antibodies and analyzed by confocal microscopy. Scale bars, 10 μm.(G) J774A.1 macrophages were infected with PR8 virus. Pure cytosolic extracts were collected at indicated time points. Oxidized DNA in the cytosol was detected by dot blot analysis using anti-8OH-dG antibody. These data are from three independent experiments (B--E; mean ± SEM).∗p \< 0.05, ∗∗p \< 0.01 and ∗∗∗p \< 0.001 versus mock-infected cells (one-way ANOVA and Tukey\'s test). See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Influenza Virus M2 or PB1-F2 Proteins Trigger Oxidized DNA Release {#sec2.2}
------------------------------------------------------------------

We previously demonstrated that ion channel activity of the influenza virus M2 protein is essential for NLRP3 inflammasome activation ([@bib13]) or mtDNA release into the cytosol ([@bib29]). Consistent with our previous observations ([@bib29]), overexpression of the M2 protein was sufficient to stimulate mtDNA release into the cytosol ([Figure 2](#fig2){ref-type="fig"}A). Since influenza virus stimulates cytosolic mtDNA release in an MAVS-dependent manner ([@bib29]), we next examined whether intracellular delivery of polyinosinic-polycytidylic acid (poly(I:C)), a synthetic analog of double-stranded RNA, into HEK293FT cells by transfection stimulates mtDNA release into the cytosol. Interestingly, we found that, although intracellular delivery of poly(I:C) was insufficient to stimulate mtDNA release into the cytosol, the PB1-F2 protein stimulated cytosolic mtDNA release in the presence of poly(I:C) or viral RNA ([Figures 2](#fig2){ref-type="fig"}A--2C). In addition, we found that ion channel activity of the M2 protein or PB1-F2 together with poly(I:C) protein stimulated oxidized DNA release into the cytosol ([Figures 2](#fig2){ref-type="fig"}D and 2E). Furthermore, the recombinant influenza virus lacking amino acids 29--31 of the M2 protein (termed rgPR8/M2del29-31), which has lost its ion channel activity and failed to stimulate the NLRP3 inflammasome-mediated IL-1β secretion ([@bib13]; [@bib29]), or the PB1-F2 protein (termed rgPR8/ΔPB1-F2) reduced its ability to stimulate mtDNA release into the cytosol ([Figures 2](#fig2){ref-type="fig"}F and 2G). These data indicate that the ion channel activity of M2 protein or PB1-F2 protein together with poly(I:C) stimulates mtDNA and oxidized DNA release into the cytosol.Figure 2Influenza Virus M2 and PB1-F2 Proteins Stimulate Oxidized DNA Release(A--C) HEK293FT cells were transfected with the expression plasmid encoding EGFP or influenza virus proteins in the presence or absence of poly(I:C) (A, B) or influenza viral RNA (C). Cytosolic mtDNA was assessed by quantitative PCR at 24 h post transfection.(D and E) HEK293FT cells were transfected with the expression plasmid encoding EGFP or influenza virus proteins in the presence or absence of poly(I:C). Pure cytosolic extracts were collected at 24 h post transfection. Oxidized DNA in the cytosol was detected by dot blot analysis using anti-8OH-dG antibody.(F and G) HEK293FT cells were infected with WT (rgPR8), rgPR8/M2del29--31 (F), or rgPR8/ΔPB1-F2 virus (G). Cytosolic mtDNA was assessed by quantitative PCR at 24 h post infection. These data are from three independent experiments (A--C, F, G; mean ± SEM).∗∗p \< 0.01 and ∗∗∗p \< 0.001 versus EGFP-transfected or rgPR8-infected cells (one-way ANOVA and Tukey\'s test).

We further examined the cellular mechanism by which PB1-F2 protein stimulates mtDNA and oxidized DNA release. We previously demonstrated that the PB1-F2 protein translocates into mitochondria via translocase of the outer membrane 40 (Tom40) channels ([@bib44]). Consistent with our previous observation ([@bib44]), knockdown of Tom40 significantly blocked cytosolic mtDNA release induced by PB1-F2 protein together with poly(I:C) without affecting the expression levels of the PB1-F2 protein ([Figures 3](#fig3){ref-type="fig"}A and 3B). In addition, a C-terminal truncated mutant of PB1-F2 protein, which failed to translocate into the mitochondrial inner membrane space ([Figure 3](#fig3){ref-type="fig"}C) ([@bib44]), lost the ability to stimulate mtDNA and oxidized DNA release in the presence of poly(I:C) ([Figures 3](#fig3){ref-type="fig"}D and 3E). Collectively, these data indicate that mitochondrial localization of PB1-F2 protein is required for mtDNA and oxidized DNA release in poly(I:C)-stimulated cells.Figure 3Mitochondrial Localization of PB1-F2 Protein Is Required for Oxidized DNA Release(A and B) HEK293FT cells were transfected with siRNA targeting Tom40, Tom22, or control siRNA. Two days later, cells were transfected with the expression plasmid encoding EGFP or PB1-F2 protein in the presence of poly(I:C). Cell lysates were collected at 24 h post transfection and blotted using the indicated antibodies (A). Cytosolic mtDNA was assessed by quantitative PCR at 24 h post transfection (B).(C) HeLa cells were transfected with expression plasmids encoding PB1-F2 or its C-terminal truncated mutant. At 24 h post transfection, cells were stained with anti-PB1-F2 and anti-Tom20 antibodies to visualize the PB1-F2 protein and mitochondria, respectively, and analyzed by confocal microscopy. Scale bars, 10 μm.(D and E) HEK293FT cells were transfected with the expression plasmid encoding EGFP, PB1-F2, or its C-terminal truncated mutant in the presence of poly(I:C). Pure cytosolic extracts were collected at 24 h post transfection. Cytosolic mtDNA was assessed by quantitative PCR (D). Oxidized DNA in the cytosol was detected by dot blot analysis using anti-8OH-dG antibody (E). These data are from three independent experiments (B, E; mean ± SEM).∗∗∗p \< 0.001 (one-way ANOVA and Tukey\'s test).

Oxidized DNA Enhances Influenza Virus-Induced IL-1β Secretion {#sec2.3}
-------------------------------------------------------------

Given that oxidized mtDNA triggers NLRP3 inflammasome activation ([@bib38]; [@bib46]), oxidized DNA could enhance influenza virus-induced IL-1β secretion. To test this idea, we generated oxidized mtDNA fragment by standard PCR using 8-oxo-dGTP ([Figure 4](#fig4){ref-type="fig"}A). Since influenza virus alone failed to induce detectable levels of pro-IL-1β and stimulated marginal amounts of IL-1β secretion ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C), we stimulated macrophages with LPS after influenza virus infection. In LPS-stimulated J774A.1 or BMMs infected with influenza virus, expression levels of PB1-F2, M2, and NS1 proteins became apparent starting around 6 h p.i. and peaking around 9 h p.i. ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). In addition, IL-1β secretion from influenza virus-infected J774A.1 or BMMs became apparent starting around 9 h p.i. and peaking around 18--24 h p.i. ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). Consistent with our previous report ([@bib13]), we detected active caspase-1 in the supernatants of the virus-infected macrophages at 24 h p.i. ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). To test whether oxidized mtDNA might enhance influenza virus-induced IL-1β secretion, we infected J774A.1 or BMMs with influenza virus in the presence of 8-oxo-dG^-^ or 8-oxo-dG^+^ DNA. Notably, oxidized mtDNA (8-oxo-dG^+^ DNA) significantly enhanced influenza virus-induced IL-1β secretion from LPS-stimulated J774A.1 and BMMs compared with control 8-oxo-dG^-^ DNA ([Figures 4](#fig4){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}D). Similarly, 8-oxo-2′-deoxyguanosine (8-oxo-dG), an oxidized derivative of deoxyguanosine, significantly increased influenza virus-induced IL-1β secretion from LPS-stimulated J774A.1 and BMMs compared with deoxyguanosine (dG) control ([Figures 4](#fig4){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}E). In addition, increased levels of influenza virus-induced IL-1β secretion by 8-oxo-dG treatment was significantly inhibited by Mcc950, a specific inhibitor of the NLRP3 inflammasome, or Ac-YVAD-cmk, a specific peptide inhibitor of caspase-1 ([Figures 4](#fig4){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}E). Furthermore, 8-oxo-dG restored IL-1β secretion from rgPR8/M2del29-31 virus-infected J774A.1 and BMMs ([Figures 4](#fig4){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}F). Conversely, treatment with antioxidant Mito-TEMPO, a scavenger specific for mitochondrial reactive oxygen species, inhibited IL-1β secretion or oxidized DNA release from influenza virus-infected J774A.1 and BMMs ([Figures 4](#fig4){ref-type="fig"}E, [S2](#mmc1){ref-type="supplementary-material"}G, and S2H). Together, these data suggest oxidized DNA may be important for the NLRP3 inflammasome-mediated IL-1β secretion after influenza virus infection.Figure 4Oxidized DNA Enhances Influenza Virus-Induced IL-1β Secretion(A) Oxidized mtDNA fragment was prepared as described in [Methods](#sec4){ref-type="sec"}. dsDNA and oxidized DNA were detected by dot blot analysis using anti-dsDNA (35I9 DNA) or anti-8OH-dG antibodies.(B) LPS-stimulated BMMs were infected with PR8 in the presence or absence of oxidized (8-oxo-dG^+^) or control (8-oxo-dG^-^) DNA.(C and D) LPS-stimulated BMMs were infected with PR8 (C), rgPR8, or rgPR8/M2del29--31 virus (D) in the presence or absence of dG (246 μM), 8-oxo-dG (246 μM), Mcc950 (20 μM), or Ac-YVAD-cmk (20 μM).(E) LPS-stimulated BMMs were infected with PR8 virus in the presence or absence of Mito-TEMPO (500 μM). Cell-free supernatants were collected and analyzed for IL-1β by ELISA (B--E). These data are from three independent experiments (B--E; mean ± SEM).∗∗∗p \< 0.001 (one-way ANOVA and Tukey\'s test). See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Influenza Virus Stimulates AIM2 Inflammasome-Dependent IL-1β Secretion {#sec2.4}
----------------------------------------------------------------------

Thus far, our data indicated influenza virus-induced oxidized DNA triggers NLRP3 inflammasome activation. Since cytosolic mtDNA triggers the absent in melanoma 2 (AIM2), a cytosolic dsDNA sensor, -dependent inflammasome activation ([@bib8]), the released mtDNA from influenza virus-infected macrophages would elicit the AIM2 inflammasome activity. To test this directly, we infected WT or AIM2-deficient BMMs with influenza virus and measured IL-1β secretion. Consistent with our previous report ([@bib22]), the recombinant herpes simplex virus 1 (HSV-1) lacking VP22 protein stimulated IL-1β secretion in an AIM2-dependent manner ([Figure 5](#fig5){ref-type="fig"}A). Notably, IL-1β secretion was significantly reduced in AIM2-deficient cells upon influenza virus infection but not ATP, an NLRP3 agonist ([Figures 5](#fig5){ref-type="fig"}B and 5C). Furthermore, a 1,277 bp of mtDNA fragment significantly enhanced influenza virus-induced IL-1β secretion from J774A.1 and BMMs ([Figures 5](#fig5){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}A). Conversely, addition of DNase I in the extracellular medium significantly blocked IL-1β secretion from influenza virus-infected J774A.1 and BMMs ([Figures 5](#fig5){ref-type="fig"}E and [S3](#mmc1){ref-type="supplementary-material"}B). These results indicated that cytosolic or extracellular mtDNA may stimulate AIM2 inflammasome-mediated IL-1β secretion from influenza virus-infected macrophages.Figure 5Influenza Virus Stimulates the AIM2 Inflammasome-Mediated IL-1β Secretion(A--C) LPS-stimulated BMMs prepared from WT or AIM2-deficient mice were infected with HSV-1ΔVP22 (A) or PR8 virus (B) for 24 h. For ATP stimulation, BMMs were stimulated with LPS for 6 h and pulsed with 2 mM ATP for 30 min (C).(D and E) LPS-stimulated BMMs were infected with PR8 virus for 24 h in the presence or absence of mtDNA fragment prepared as described in [Methods](#sec4){ref-type="sec"} (D) or DNase I (E). Cell-free supernatants were collected and analyzed for IL-1β by ELISA. These data are from three independent experiments (mean ± SEM).∗∗p \< 0.01, ∗∗∗p \< 0.001 (one-way ANOVA and Tukey\'s test). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

Influenza virus stimulates the NLRP3 inflammasome-mediated IL-1β secretion from macrophage through its M2 ion channel activity ([@bib13]) or the PB1-F2 aggregates ([@bib26]; [@bib34]). However, the precise mechanism by which these viral proteins trigger NLRP3 inflammasome activation remains unclear. In this study, we demonstrated that ion channel activity of the M2 protein or mitochondrial localization of the PB1-F2 through Tom40 channel was essential for oxidized DNA release. We found that these cytosolic or extracellular DNA stimulated both NLRP3 and AIM2 inflammasome-mediated IL-1β secretion from macrophages.

Mitochondria play a central role in NLRP3 inflammasome activation ([@bib41]). ROS-producing damaged mitochondria was first implicated in NLRP3 inflammasome activation ([@bib48]). Consistent with this observation, cytosolic oxidized mtDNA was found to be important for NLRP3 inflammasome activation ([@bib38]; [@bib46]). Translocation of mtDNA into the cytosol required activation of the NLRP3 or MAVS, mitochondrial ROS production, or formation of mitochondrial permeability transition (MPT) pores or BAK/BAX macropores ([@bib23]; [@bib29]; [@bib30]). In addition to their role in NLRP3 inflammasome activation, mitochondria also act as platforms for the NLRP3 inflammasome activation. MAVS interacts with the NLRP3 and promotes its localization to the mitochondria for full activation of the NLRP3 inflammasome ([@bib40]). Following influenza virus infection, the NLRP3 associates with mitofusin 2 to facilitate its localization to the mitochondria ([@bib15]). In this study, we found that the M2 protein of influenza virus was sufficient to trigger oxidized DNA release. Since Ca^2+^ overload is sufficient to induce the MPT ([@bib20]), we speculate that the M2-mediated perturbation of intracellular ionic concentrations may be sufficient to stimulate formation of Ca^2+^ influx-dependent MPT pores and cytosolic release of oxidized mtDNA. Interestingly, a recent study has demonstrated that disassembly of *trans-*Golgi network into vesicles serves as a scaffold for NLRP3 aggregation and activation ([@bib4]). Since the M2-induced activation of inflammasomes required its localization to the Golgi apparatus ([@bib13]), it is possible that the M2 protein promotes *trans-*Golgi network disassembly into vesicles and NLRP3 aggregation. In contrast to the M2 protein, the PB1-F2 protein required intracellular delivery of poly(I:C) or viral RNA to stimulate oxidized mtDNA release. Although the PB1-F2-mediated reduction of mitochondrial membrane potential may cause mitochondrial ROS production ([@bib44]; [@bib48]), it was insufficient to stimulate oxidized mtDNA release. Thus, mitochondria-localized PB1-F2 protein and MAVS-dependent signals may act synergistically to stimulate oxidized mtDNA release into the cytosol.

Not surprisingly, influenza virus has evolved strategies to counteract host innate antiviral immune responses. We and others previously demonstrated that the NS1 protein of influenza virus suppressed the NLPR3 inflammasome-mediated IL-1β secretion from macrophages ([@bib6]; [@bib27]; [@bib39]). Interestingly, the RNA-binding domain of the NS1 protein was essential for the NLRP3 inflammasome-mediated IL-1β secretion ([@bib27]). More recently, we showed that the RNA-binding domain of the NS1 protein was important for association with cytosolic mtDNA to suppress the stimulator of interferon genes (STING)-dependent interferon responses ([@bib29]). These observations suggest that the NS1 protein of influenza virus inhibits the NLRP3 inflammasome-mediated IL-1β secretion by inhibiting the MAVS-dependent mtDNA release or sequestering cytosolic mtDNA.

Inflammasome-dependent cytokine production in the lung of influenza virus-infected mice plays an essential role in the induction of virus-specific adaptive immune responses and in the initiation of tissue repair responses following infectious damage ([@bib1]; [@bib12], [@bib14]; [@bib28]; [@bib32]). Somewhat surprisingly, induction of the influenza virus-specific adaptive immune responses was dependent of ASC and caspase-1 but not NLRP3 ([@bib12]). Recent reports indicated that the AIM2 plays an important role in IL-1β secretion in the lung of influenza virus-infected mice ([@bib36]; [@bib45]). We and others detected mitochondrial or nuclear DNA in the bronchoalveolar (BAL) fluid of influenza virus-infected mice ([@bib29]; [@bib36]). In this study, we detected dsDNA in extracellular web-like structures of influenza virus-infected macrophages. In addition, we showed that influenza virus stimulated the AIM2 inflammasome-mediated IL-1β secretion from macrophages. These observations suggest that activation of both NLRP3 and AIM2 inflammasomes in the lung of influenza virus-infected mice may play an important role in the induction of virus-specific adaptive immune responses or influenza-associated mortality. In addition to influenza viral RNA ([@bib19]), mitochondrial or nuclear DNA could act as ligands for these inflammasomes in the lung tissue.

In summary, our data reveal a missing link between influenza virus M2 or PB1-F2 proteins and the NLRP3 inflammasome activation. Both M2 and PB1-F2 proteins stimulated oxidized DNA release to trigger the NLRP3 and AIM2 inflammasomes activation. Because both M2 and PB1-F2 proteins contribute virulence of influenza A viruses ([@bib5]; [@bib7]; [@bib25], [@bib24], [@bib26]), our findings suggest a possible effect of influenza virus-induced oxidized DNA in pathogenesis of influenza A virus infections. Better understanding of the role of the M2 and PB1-F2 proteins in regulating inflammatory responses *in vivo* and pathogenesis of influenza virus infections will aid the development of more effective interventions for the treatment of influenza virus-associated diseases.

Limitations of the Study {#sec3.1}
------------------------

In the present study, we demonstrated that influenza virus stimulates oxidized DNA release from macrophages. Although we detected significant amounts of both mitochondrial and nuclear DNA in cytosol and supernatants of influenza virus-infected macrophages, the current study does not determine the relative contributions of mtDNA versus nuclear DNA in activation of the NLRP3 and AIM2 inflammasomes. In addition, we showed that ion channel activity of the M2 protein or mitochondrial localization of the PB1-F2 protein is required for oxidized DNA release. We generated recombinant influenza viruses lacking amino acids 29--31 of the M2 protein or PB1-F2 protein to examine the effect of deficiency of the M2 ion channel activity or PB1-F2 protein in influenza virus-induced IL-1β secretion. However, we found that the expression levels of the M2 and PB1-F2 proteins were different between WT and the mutant virus-infected macrophages. Thus, we cannot simply compare the ability to stimulate inflammasome-dependent IL-1β secretion from macrophages infected with rgPR8 (WT), rgPR8/M2del29-31, or rgPR8/ΔPB1-F2 virus. Since virus-encoded ion channels (viroporins) of other RNA viruses such as encephalomyocarditis virus and severe acute respiratory syndrome coronavirus activate the NLRP3 inflammasome ([@bib3]; [@bib16]; [@bib31]), future studies to dissect the importance of the viroporins in oxidized DNA release and activation of the NLRP3 and AIM2 inflammasomes will be important extensions of this work.
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